Daratumumab as a treatment for adult immune thrombocytopenia: a phase ii studyWith safety run-in (the dart study)

Galina  Tsykunova; Pal André  Holme; H. Thi Thyuet Tran; Tor Henrik  Anderson Tvedt; Ludvig Andre  Munthe; Marc Michel; Henrik Frederiksen

Daratumumab as a treatment for adult immune thrombocytopenia: a phase ii studyWith safety run-in (the dart study)

Galina Tsykunova^*, Pal André Holme, H. Thi Thyuet Tran, Tor Henrik Anderson Tvedt, Ludvig Andre Munthe, Marc Michel, Henrik Frederiksen

^*Corresponding author for this work

Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review

Original language	English
Publication date	Jun 2022
Publication status	Published - Jun 2022
Event	EHA 2022 Hybrid Congress - Vienna, Austria Duration: 9. Jun 2022 → 12. Jun 2022

Conference

Conference	EHA 2022 Hybrid Congress
Country/Territory	Austria
City	Vienna
Period	09/06/2022 → 12/06/2022

Cite this

@conference{9f83a4c134cc42818d841e7265e61a21,

title = "Daratumumab as a treatment for adult immune thrombocytopenia: a phase ii studyWith safety run-in (the dart study)",

author = "Galina Tsykunova and Holme, {Pal Andr{\'e}} and Tran, {H. Thi Thyuet} and {Anderson Tvedt}, {Tor Henrik} and Munthe, {Ludvig Andre} and Marc Michel and Henrik Frederiksen",

year = "2022",

month = jun,

language = "English",

note = "EHA 2022 Hybrid Congress ; Conference date: 09-06-2022 Through 12-06-2022",

}

TY - CONF

T1 - Daratumumab as a treatment for adult immune thrombocytopenia: a phase ii studyWith safety run-in (the dart study)

AU - Tsykunova, Galina

AU - Holme, Pal André

AU - Tran, H. Thi Thyuet

AU - Anderson Tvedt, Tor Henrik

AU - Munthe, Ludvig Andre

AU - Michel, Marc

AU - Frederiksen, Henrik

PY - 2022/6

Y1 - 2022/6

M3 - Poster

T2 - EHA 2022 Hybrid Congress

Y2 - 9 June 2022 through 12 June 2022

ER -